(Q28343546)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

0 references

1 reference

1 reference

E Miyazaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

R E Chaisson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

W R Bishai

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

language of work or name

English

0 references

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

12 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

2126-2130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

12 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Mechanisms of latency in Mycobacterium tuberculosis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Controlled chemoprophylaxis trials in tuberculosis. A general review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

The global tuberculosis situation and the new control strategy of the World Health Organization

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89434

A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council

27 November 2018

1 reference

12 December 2020

Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice

1 reference

12 December 2020

Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)

1 reference

12 December 2020

The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis

1 reference

12 December 2020

An Outbreak Involving Extensive Transmission of a Virulent Strain ofMycobacterium tuberculosis

1 reference

12 December 2020

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

1 reference

12 December 2020

Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report

1 reference

12 December 2020

Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong

1 reference

12 December 2020

Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis

1 reference

12 December 2020

A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis

1 reference

12 December 2020

Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]

1 reference

12 December 2020

Pharmacokinetics of rifapentine, a new long lasting rifamycin, in the rat, the mouse and the rabbit

1 reference

12 December 2020

Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.43.9.2126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10471552%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

PubMed publication ID

10471552

1 reference